We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$30B
1-Year Est. Return
76.99%
This Fund
S&P 500
This Quarter
Est. Return
+43.51%
1 Year Est. Return
+76.99%
3 Year Est. Return
+326.24%
5 Year Est. Return
+435.69%
10 Year Est. Return
+2,724.6%
AUM
$30B
AUM Growth
+$7.24B
(+32%)
Cap. Flow
+$923M
Cap. Flow
% of AUM
3.08%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
509
New
65
Increased
131
Reduced
225
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$982M |
| 2 |
NVIDIA
NVDA
|
+$276M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$211M |
| 4 |
Lumentum
LITE
|
+$203M |
| 5 |
Advanced Micro Devices
AMD
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NBIS
Nebius Group N.V.
NBIS
|
+$767M |
| 2 |
Astera Labs
ALAB
|
+$342M |
| 3 |
Western Digital
WDC
|
+$221M |
| 4 |
Intuitive Surgical
ISRG
|
+$121M |
| 5 |
AstraZeneca
AZN
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.55% |
| 2 | Communication Services | 18% |
| 3 | Industrials | 12.18% |
| 4 | Consumer Discretionary | 11.21% |
| 5 | Healthcare | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVR
351
Anteris Technologies
AVR
$840M
| $1.26M | ﹤0.01% |
+128,257
| New | +$976K |
|
352
Trevi Therapeutics
TRVI
$2.4B
| $1.24M | ﹤0.01% |
+66,490
| New | +$967K |
|
353
Ligand Pharmaceuticals
LGND
$5.76B
| $1.23M | ﹤0.01% |
3,898
-1,791
| -31% | -$422K |
|
354
Palomar
PLMR
$3.53B
| $1.21M | ﹤0.01% |
9,594
-74,613
| -89% | -$8.78M |
|
|
ALMS
355
Alumis Inc
ALMS
$1.37B
| $1.21M | ﹤0.01% |
+43,057
| New | +$1M |
|
356
Butterfly Network
BFLY
$2B
| $1.2M | ﹤0.01% |
+142,524
| New | +$738K |
|
357
Unity
U
$18.8B
| $1.16M | ﹤0.01% |
40,562
+29,499
| +267% | +$785K |
|
358
Vertex
VERX
$2.1B
| $1.12M | ﹤0.01% |
97,694
-1,403
| -1% | -$17.5K |
|
359
Texas Instruments
TXN
$236B
| $1.12M | ﹤0.01% |
+3,748
| New | +$1.04M |
|
360
Pricesmart
PSMT
$5.34B
| $1.1M | ﹤0.01% |
5,610
-1,095
| -16% | -$183K |
|
361
Stryker
SYK
$106B
| $1.05M | ﹤0.01% |
3,335
-8,173
| -71% | -$2.58M |
|
362
Tenax Therapeutics
TENX
$74.1M
| $1.05M | ﹤0.01% |
+71,967
| New | +$919K |
|
|
EMBJ
363
Embraer S.A. ADS
EMBJ
$13.2B
| $999K | ﹤0.01% |
15,658
-138
| -0.9% | -$8.47K |
|
364
Descartes Systems
DSGX
$6.47B
| $985K | ﹤0.01% |
14,220
-20,069
| -59% | -$1.43M |
|
365
Costco
COST
$404B
| $941K | ﹤0.01% |
1,006
-2,780
| -73% | -$2.77M |
|
366
Protagonist Therapeutics
PTGX
$9.44B
| $938K | ﹤0.01% |
+7,650
| New | +$799K |
|
367
Illumina
ILMN
$31.9B
| $921K | ﹤0.01% |
5,237
+3,508
| +203% | +$514K |
|
368
Laureate Education
LAUR
$5.01B
| $917K | ﹤0.01% |
25,242
-3,608
| -13% | -$122K |
|
369
Enphase Energy
ENPH
$5.13B
| $902K | ﹤0.01% |
+18,319
| New | +$834K |
|
370
HCA Healthcare
HCA
$87B
| $896K | ﹤0.01% |
2,299
-1,516
| -40% | -$641K |
|
371
United Therapeutics
UTHR
$21.4B
| $883K | ﹤0.01% |
1,629
-2,893
| -64% | -$1.63M |
|
372
Archer Aviation
ACHR
$4.49B
| $875K | ﹤0.01% |
184,961
-2,713
| -1% | -$15.8K |
|
373
Edwards Lifesciences
EW
$50B
| $875K | ﹤0.01% |
9,670
-32,771
| -77% | -$2.75M |
|
374
Sportradar
SRAD
$3.77B
| $851K | ﹤0.01% |
+56,848
| New | +$827K |
|
375
CRH
CRH
$60.3B
| $845K | ﹤0.01% |
7,896
-16,474
| -68% | -$1.81M |
|
Similar funds
GMC
OAG
Fred Alger Management's Q2 2026 Portfolio in Review
As of Q2 2026, Fred Alger Management held 509 positions worth $30B, up 32% from $22.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Fred Alger Management deployed $923M of net new capital in Q2 2026, opening 65 new positions and adding to 131 existing holdings. Its largest new stake was SpaceX: 5,779,419 shares worth $987M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Nebius Group N.V., an estimated $767M trimmed.
- Fred Alger Management's largest Q2 2026 buy was SpaceX: 5,779,419 shares worth $987M.
- Fred Alger Management added most to NVIDIA in Q2 2026, an estimated $276M increase.
- Fred Alger Management's biggest Q2 2026 reduction was Nebius Group N.V., cutting an estimated $767M.
- Fred Alger Management fully exited Palantir in Q2 2026, selling an estimated $95.2M.
- Fred Alger Management's ten largest holdings make up 54% of its $30B portfolio in Q2 2026.
- Fred Alger Management opened 65 new positions and closed 84 in Q2 2026.
- Fred Alger Management's portfolio value rose 32% quarter-over-quarter to $30B.
Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.